Table 1.
Groups | Dose | Cell Viability |
---|---|---|
Con | — | 1.00 ± 0.021 |
17β-E2(μM) | 1 | 1.25 ± 0.015 ** |
Yam (mg/mL) | 1 | 1.31 ± 0.023 ** |
10−1 | 1.26 ± 0.028 ** | |
10−2 | 1.19 ± 0.022 * | |
10−3 | 1.17 ± 0.030 * | |
10−4 | 1.09 ± 0.027 |
* p < 0.05; ** p < 0.01 compared to the control group.